BACE1 and Alzheimer disease: Several research groups showed that the miR-29 is potentially involved in the regulation of APP and BACE1 expression because in vitro studies revealed that in sporadic AD patients, displaying abnormally high BACE1 protein levels, the miR-29 cluster was significantly decreased16, 19, 21.